Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET
Timing of hormone therapy affects risk of developing Alzheimer's|
Date: 2012-10-26 02:03:57
Medical News Today has reported that new research published in the journal Neurology shows that women who undergo hormone therapy within five years of menopause may have a decreased risk of developing Alzheimer's, while women who begin the treatment later may have an increased risk of forming dementia.
Peter P. Zandi, Ph.D., of Johns Hopkins University, and his colleagues noticed conflicting reports about whether hormone therapy was a risk factor of the degenerative disease. They noticed that observational studies, which analyze subjects over a period of time, showed that there was a risk of developing Alzheimer's when taking hormone therapy, whereas clinical studies, which involve a control group taking a placebo, suggested that the menopause treatment increased the risk of developing the neurological disorder.
The researchers conducted a study in which they monitored 1,768 women - 1,105 of whom used hormone therapy - for 11 years. The study also kept track of when each woman started menopause.
Of the 1,1768 subjects, 176 developed Alzheimer's: 87 of these women utilized hormone therapy and the other 89 patients with Alzheimer's did not. Statistical analysis showed that using hormone therapy within five years of menopause, reduced the risk of developing the disorder by 30 percent. There was an increased risk among the women who started the therapy more than five years after into post-menopause if they used combined treatments of estrogen and progestin.
While the research does have implications for when a patient should undergo hormone therapy, the study authors reported that there needs to be further research conducted to find a concrete link between the timing of the therapy and the development of Alzheimer's.
Gene mutation may hinder immune system from preventing Alzheimer's|
Date: 2012-11-15 22:21:13
According to The New York Times, two separate studies recently published in the New England Journal of Medicine revealed that a mutation in a certain gene known as TREM2 may hinder the immune system's ability to protect the brain from Alzheimer's disease.... Full Story
News Categories:Advanced Lipid Treatment I Allergy Testing Anemia and RBC disorders Autoimmune Diseases Bariatric Lab Testing Blood and Blood Diseases Breast Cancer Detection and Tumor Markers Celiac Disease Testing Chlamydia Coagulation and blood clotting disorders Colon Diabetes DNA, Paternity and Genetic testing Drug Screening Environmental Toxin Testing Female Specific Tests Gastrointestinal Diseases General Health General Wellness Heart Health and Cholesterol Herpes HIV HIV monitoring/Treatment/Testing/Post Diagnos Hormones and Metabolism Infectious Diseases Infertility Testing-Male Infertitlity Hormone Testing Kidney Diseases Leukemia and WBC disorders Liver Liver Diseases Lyme Disease Male Specific Tests Menopause/Peri-Menopausal Diagnosis Musculoskeletal Diseases Organ Specific Testing Ovarian Prostate Sexually Transmitted Diseases Thyroid Diseases Transgender Hormone Testing-female to male Transgender Hormone Testing-Male to Female Vitamin D Deficiency-Diagnosis and Treatment
Visit the Health News Archive: Click Here
Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our certified professionals are ready to assist you.Back to top